260.Diagnostics: Detecting Esophageal Precancer with Lishan Aklog, CEO of Lucid Diagnostics

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions00:00 Introduction to MedTech and Cancer Prevention03:01 Dr. Lishan Acklog's Journey in Medicine05:59 The Impact of Cardiac Surgery and Influential Figures12:07 Transitioning from Surgery to Entrepreneurship17:59 Founding Lucid Diagnostics and the Focus on Esophageal Cancer24:04 Understanding Esophageal Cancer and Its Challenges31:53 Understanding Esophageal Cancer and Its Causes35:18 The Role of EsoGuard in Early Detection39:36 Innovative Cell Collection Techniques46:41 Commercial Strategies for Patient Access51:44 Reimbursement Challenges and Solutions57:17 Clinical Performance and Market PotentialAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our newsletter: https://www.stateofmedtechpodcast.com/Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgFollow The State of MedTech on:⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠TikTok⁠⁠⁠⁠X⁠⁠⁠⁠Facebook⁠⁠⁠⁠Follow Omar M. Khateeb on⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠TikTok⁠⁠⁠⁠X⁠⁠⁠⁠Facebook⁠⁠